Low risk of development of substance dependence for barbiturates and clobazam prescribed as antiepileptic drugs: Results from a questionnaire study

CNS Neuroscience and Therapeutics

Volumn 15, Issue 1, 2009, Pages 24-31

  Uhlmann, Carmen ^a   Fröscher, Walter ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Addiction; Antiepileptic drugs (AED); Barbiturates; Clobazam; Dependence; Epilepsy; Outcome expectation

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CLOBAZAM;

ADULT; ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEIZURE; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BARBITURATES; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 60349094259     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2008.00073.x     Document Type: Article

References (29)

1. Salzman C. Addiction to benzodiazepines. Psychiatr Q 1989 69 : 251 261.
2. Ward FD, Bower A. A study of certain aspects of epilepsy in childhood. Develop Med Child Neurol 1978 73 : 1 20.
3. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997 38 : 233 236.
4. Bauer J. Epilepsietherapie im erwachsenenalter (Treatment of epilepsy in adults. Options and strategies). Nervenarzt 2007 78 (Suppl 1 27 36.
5. Bauer G. Kopfschmerzen bei Anfallskrankheiten. In : Barolin GS, Saurugg WD, Hemmer W, editors. Kopfschmerz/Headache. München : Lehmanns, 1975 p. 436 437.
6. Gostomzyk JG, Heller W-D. Langzeitanwendung von Betäubungsmitteln in der Schmerztherapie (Long-term use of narcotics in pain therapy). Dtsch Med Wschr 1990 115 : 763 770.
7. Uhlmann C, Fröscher W. Dependence on antiepileptic drugs: Does it exist? Epileptologia 2007 15 : 41 47.
8. Uhlmann C, Rösche J, Fröscher W. Dependence on antiepileptic drugs. Epilepsia 2002 43 (Suppl 8 116.
9. Bandura A. Self-efficacy: Towards a unifying theory of behavioral change. Psychol Review 1977 1077 : 191 215.
10. Marlatt GA, Demming B, Reid JB. Loss of control drinking in alcoholics: An experimental analogue. J Abnorm Psychol 1973 81 : 223 241.
11. Stacy AW, Newcomb MD, Bentler PM. Cognitive motivation and drug use: A 9-year longitudinal study. J Abnorm Psychol 1991 100 : 502 515.
12. Kobau R, DiIorio C. Epilepsy self-management: A comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviours among people with epilepsy. Epilepsy Behav 2003 4 : 217 225.
13. Frey HH, Fröscher W, Koella WP, Meinardi H, editors. Tolerance to beneficial and adverse effects of antiepileptic drugs. New York : Raven, 1986.
14. Fröscher W, Blankenhorn V, May TW, Neher K-D, Rambeck B, Steinhoff BJ. Pharmakotherapie der Epilepsien. 4th ed. Stuttgart, New York : Schattauer, 2008.
15. Landry MJ, Smith DE, McDuff DR, Baughman OL. Benzodiazepine and withdrawal: Identification and medical management. J Am Board Fam Pract 1992 5 : 225 226.
16. Linden M, Bär T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med 1998 28 : 721 729.
17. Faust V, Baumhauer H. Medikamenten abhängigkeit. In : Faust V, editor. Psychiatrie. New York : Fischer, 1995.
18. Hentschel B, Fröscher W. Clobazam in the treatment of epilepsy. Drugs Today 1992 28 : 567 572.
19. Michael B, Marson AG. Clobazam as add-on in the management of refractory epilepsy. Cochrane Database Syst Rev 2008 CD004154. DOI :.
20. Kruse HJ. Psychopharmacology of clobazam with special reference to its anticonvulsant activity. In : Hindmarch I, Stonier PD, Trimble MR, editors. Clobazam. International Congress and Symposium Series. Vol 74. London, UK : Royal Society of Medicine Services Limited, 1985.
21. Uhlmann C, Fröscher W. Abhängigkeitspotential von Antiepileptika. In : Fröscher W, Bauer G, Krämer G, editors. Epilepsie therapie. Bad Honnef: Hippocampus. 2000. p. 55 64.
22. Widdess-Walsh P, Devinsky O. Antiepileptic drug resistance and tolerance in epilepsy. Rev Neurol Dis 2007 4 : 194 202.
23. Löscher W, Schmidt D. Experimental and clinical evidence of the loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 2006 47 : 1253 1284.
24. O'Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005 66 (Suppl 2 28 33.
25. Malcom R, Myrick H, Brady KT, Ballenger JC. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addiction 2001 10 : 16 23.
26. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, et al. Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA 2007 298 : 1641 1651.
27. Minozzi S, Amato L, Davoli M, Farrell M, Lima Reisser AA, Pani PP, Silva de Lima M, Soares B, Vecchi S. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev 2008 16 : CD006754.
28. Kristensen O, Lolandsmo T, Isaksen J, Verderhus J-K, Clausen T. Treatment of polydrug-using opiate dependents during withdrawal: Towards a standardisation of treatment. BMC Psychiat 2006 6 : 54 doi :.
29. Zullino DF, Khazaal Y, Hättenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today 2004 40 : 603 619.